|
|
Line 1: |
Line 1: |
| {| style="cellpadding=0; cellspacing= 0; width: 600px;"
| | |
| |-
| |
| | style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align=center | '''Drug''' || style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align=center | '''Dosage'''
| |
| |-
| |
| | style="padding: 0 5px; font-size: 90%; background: #F5F5F5;" align=center | '''''Agents with proven efficacy'''''
| |
| |-
| |
| | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Dofetilide]] (I A)''''' || style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''Creatinine clearance(ml/min): <br> > 60 - 500 mg <br> 40 to 60 - 250 mg <br> 20 to 40 - 125 mg <br> < 20 - contraindicated'''''
| |
| |-
| |
| | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Flecainide]] (I A)''''' || style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ ''''' Oral: 200 to 300 mg <br> Intravenous: 1.5 to 3.0 mg/kg over 10 to 20 min'''''
| |
| |-
| |
| | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ibutilide]] (I A)''''' || style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''1 mg over 10 min; repeat 1 mg when necessary'''''
| |
| |-
| |
| | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Propafenone]] (I A)''''' || style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ ''''' Oral: 600 mg <br> Intravenous: 1.5 to 2.0 mg/kg over 10 to 20 min'''''
| |
| |-
| |
| | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Amiodarone]] (IIa A) ''''' || style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ ''''' Oral:'''''
| |
| : '''''Inpatient: 1.2 to 1.8 g per day in divided dose until 10 g total <br> then 200 to 400 mg per day maintenance or 30 mg/kg as single dose''''' <br>
| |
| : '''''Outpatient: 600 to 800 mg per day divided dose until 10 g total <br> then 200 to 400 mg per day maintenance.''''' <br>
| |
| '''''Intravenous:'''''
| |
| : '''''5 to 7 mg/kg over 30 to 60 min then 1.2 to 1.8 g per day continuous IV or''''' <br>
| |
| : '''''in divided oral doses until 10 g total then 200 to 400 mg per day maintenance.'''''
| |
| |-
| |
| |}
| |